Physician profile
Eric Kristopher James
NPI 1235692468
$6,482.54
in general payments reported to CMS, 2019-2025
17 companies · $5,066 in 2025
The $5,066 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.95 · 2020: $69.87 · 2021: $700 · 2022: $240 · 2023: $173 · 2024: $170 · 2025: $5,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,008 · Travel and Lodging: $2,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,008.41 |
| Travel and Lodging | $2,400.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $4,150.13 | 2020-2025 | |
| Alcon Vision LLC | $730.39 | 2021-2025 | Hydrus Microstent, Voyager Dslt, Tryptyr |
| Sun Pharmaceutical Industries INC. | $250.14 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $220.32 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.93 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $175.55 | 2025 | Xiidra, Miebo |
| Aerie Pharmaceuticals, INC. | $159.57 | 2021 | |
| Sight Sciences, INC. | $148.74 | 2025 | Tearcare System |
| Apellis Pharmaceuticals, INC. | $124.99 | 2025 | Syfovre |
| Kala Pharmaceuticals, INC. | $67.81 | 2021 | |
| Lkc Technologies, INC. | $56.60 | 2025 | |
| Novartis Pharmaceuticals Corporation | $51.84 | 2020-2022 | |
| Optos, INC. | $45.46 | 2019 | |
| Oyster Point Pharma, INC. | $26.36 | 2025 | Ryzumvi, Tyrvaya |
| Dompe US, INC. | $24.21 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.97 | 2021 | |
| Coopervision INC. | $19.53 | 2025 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.